DTC Act of 2021

Hozzl · 2022-12-31T05:25:48Z

Explore the details of Senate Bill 2304 DTC Act of 2021 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/31/2022, 5:25 AM

Congressional Summary of S 2304

Drug-Price Transparency for Competition Act of 2021 or the DTC Act of 2021

This bill requires consumer advertisements for drugs and biologics covered under Medicare or Medicaid to include the drug's list price.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2304

Bill S 2304 is currently in the status of Bill Introduced since June 24, 2021. Bill S 2304 was introduced during Congress 117 and was introduced to the Senate on June 24, 2021. Bill S 2304's most recent activity was Read twice and referred to the Committee on Finance. (text: CR S4780-4781) as of June 24, 2021

Bipartisan Support of Bill S 2304

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2304

Primary Policy Focus

Health

Alternate Title(s) of Bill S 2304

A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.

DTC Act of 2021

Drug-Price Transparency for Competition Act of 2021